# Assertio Therapeutics, Inc. – FDA Inspection, Nov 2, 2016

Source: https://www.keypedia.com/records/fda_inspections/assertio-therapeutics-inc/c0034c20-fea7-4ce7-86ba-e7c6a6ba6ccb
Source feed: FDA_Inspections

> FDA inspection 991565 of Assertio Therapeutics, Inc., November 02, 2016. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 991565
- Company Name: Assertio Therapeutics, Inc.
- Inspection Date: 2016-11-02
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1281169 - 2025-09-04
- FDA Inspection 1192639 - 2022-11-09
- FDA Inspection 1163048 - 2022-02-22
- FDA Inspection 1141337 - 2021-03-26
- FDA Inspection 662609 - 2010-05-25

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/kristin-m-abaonza/cf909da8-837d-4dfe-9ccc-288b24d7bba3)
- [FDA Associated Person](https://www.keypedia.com/people/lucila-b-nwatu/3d1c9670-8206-425c-bddd-32e395293042)

Company: https://www.keypedia.com/companies/assertio-therapeutics-inc/b3e30900-d46d-47b0-996f-f4217eecbcd2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c